You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers

Article metrics

Article menu

Download PDFPDF

XML
Commentary
Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers

 

Online download statistics by month:

Online download statistics by month: July 2021 to July 2025

AbstractFullPdf
Jul 202121621630
Aug 202115615626
Sep 2021767619
Oct 202184844
Nov 2021626210
Dec 2021545611
Jan 202230314
Feb 202218183
Mar 2022262610
Apr 2022273311
May 2022272713
Jun 202237408
Jul 202219196
Aug 202227276
Sep 202229298
Oct 2022323413
Nov 2022994
Dec 202210103
Jan 202316163
Feb 202341414
Mar 2023101110
Apr 2023111113
May 2023886
Jun 2023661
Jul 2023776
Aug 2023884
Sep 2023772
Oct 2023888
Nov 202313133
Dec 202314143
Jan 20249102
Feb 2024202015
Mar 2024171726
Apr 2024161612
May 2024995
Jun 202423237
Jul 202428295
Aug 20241096
Sep 202414146
Oct 2024252511
Nov 202414157
Dec 20249101
Jan 202517177
Feb 202514142
Mar 202515156
Apr 202538388
May 2025171816
Jun 2025994
Jul 2025110
Total13931412398